Minneapolis, MN – According to filings with the U.S. Securities and Exchange Commission, Medical 21 is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Manny Villafana played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Medical 21

Our founder, Manny Villafana, Ph.D.Sc., started Medical 21 to significantly improve the quality of life for cardiac bypass patients by eliminating the need to surgically remove vessels from the legs and arms prior to bypass surgery. Medical 21, Inc. is a developmental stage medical device company.  We are developing and intend to commercialize and market an artificial graft to bypass lesions in the heart and other parts of the patient. Manny has put together a team who collectively possess decades of experience in the successful development, manufacturing, sales, and marketing of medical products to the domestic and international healthcare markets. 

To learn more about Medical 21, visit http://www.medical21.com/

Contact:
Manny Villafana, Chief Executive Officer
612-670-5507
https://www.linkedin.com/in/manny-villafana-0451231a9/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved